Masthead

Can Aspirin Reduce Risk for Cancer Metastasis?

| Comments (0)

Results from a report released today in a leading medical journal indicate that low dose daily aspirin reduces the risk of metastasis of several cancers. According to articles in The Lancet, the protective effect occurs within 3-5 years of beginning aspirin use.

Read more about the study in a post from our Cancer Frontline blog.

Raymond DuBois, M.D., Ph.D, MD Anderson's provost and executive vice president and a professor of cancer biology and cancer medicine, shares his insights on the study's significance and addresses questions about aspirin dose, and how cancer patients should respond to this news.

Leave a comment

Search

Connect on social media

Sign In

Archives